Market Size The global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine market, valued at USD 7.5 million in 2024, is projected to reach USD 13.6 million by 2031, registering a compound annual growth rate (CAGR) of 9.1% during the forecast period. This consistent growth trajectory is largely driven by increasing demand for pharmaceutical intermediates, particularly for ibrutinib synthesis, and expandi..